Fibrin-Selective Thrombolytic Therapy for Acute Myocardial Infarction
Author:
- 1 March 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 93 (5) , 857-865
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Functional properties of recombinant staphylokinase variants obtained by site-specific mutagenesis of methionine-26Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1994
- Thrombolysis in Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Strokes, statistics and sophistry in trials of thrombolysis for acute myocardial infarctionThe American Journal of Cardiology, 1993
- On the molecular interactions between plasminogen-staphylokinase, α2-antiplasmin-formula> and fibrinBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1992
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- Coronary Thrombolysis with Tissue-Type Plasminogen Activator in Patients with Evolving Myocardial InfarctionNew England Journal of Medicine, 1984
- Clot-Selective Coronary Thrombolysis with Tissue-Type Plasminogen ActivatorScience, 1983
- Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial InfarctionNew England Journal of Medicine, 1980
- Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1979